Delivery Order SPE2DB20D2104-SPE2DB23FT03B
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $21,451.77 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $40,334.03, is for the delivery of BIKTARVY 50-200-25 30S, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
- This federal contract award, with ID SPE2DX15D3016|SPE2DX22FBVR1, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $86,176.86 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award, valued at $8,672.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a specialty pharmaceutical product. This award is a delivery order placed against Cencora, Inc.'s Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $36,315.80 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET. The contract has an ultimate completion date of May 2, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6FCR, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $31,938.44 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $44,064.72 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary...
- This federal contract award, valued at $91,929.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the provision of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award, with ID SPE2DX15D2205|SPE2DX24F74ZU, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $22,232.26 Firm Fixed Price Delivery Order is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to support federal healthcare programs. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $21,494.92 for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT03BDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $5,322.86 firm-fixed-price delivery order covers the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to support military and government healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 4/11/23 |